MJardin announces standing offer agreement with Alberta Gaming, Liquor and Cannabis

MJardin announces standing offer agreement with Alberta Gaming, Liquor and Cannabis
TORONTO – MJardin Group, Inc. (CSE: MJAR) a leader in premium cannabis production, reported that it has been registered to sell cannabis through Alberta Gaming, Liquor and Cannabis, and has entered into a standing offer agreement with AGLC for the sale of its premium high-quality cannabis in the Alberta market, under the Flint & Embers and BLLRDR brands. AGLC is... Read More

Barrick says Tanzanian assets deliver on production 

Barrick says Tanzanian assets deliver on production 
BULYANHULU GOLD MINE – The North Mara and Bulyanhulu gold mines both produced near the top end of their production guidance in 2020, their first full year under Barrick’s management. Including Buzwagi, the Tanzanian assets delivered a combined output of 462,472 ounces for the year. The mines have been successfully revived, with North Mara delivering significant improvements and underground production... Read More

Field Trip Health to Trade on the OTCQX Best Market

Field Trip Health to Trade on the OTCQX Best Market
TORONTO – Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF), a leader in the development and delivery of psychedelic therapies, reported its common shares have been approved for trading on the OTCQX® Best Market retaining its current symbol FTRPF, effective as of the opening of trading today, January 28, 2021. Field Trip’s shares and warrants continue to trade on... Read More

DIAGNOS reopens medical testing operations in Panama

DIAGNOS reopens medical testing operations in Panama
BROSSARD – Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI),  today reported the reopening of its operations in Panama. “Following a long-standing presence in Panama and in collaboration with Retina & Eye, DIAGNOS’ distributor, we have proven the effectiveness of DIAGNOS’... Read More